Why is Glenmark Pharma falling/rising?

As of 07-Jul, Glenmark Pharmaceuticals Ltd. is experiencing a price increase, currently at 1,862.35, reflecting a rise of 30.85 (1.68%). The stock has recently hit a new 52-week high of Rs. 1879.2 and has outperformed its sector by 1.76%. Over the past week, Glenmark has gained 6.46%, and in the last month, it has risen by 17.13%. The company has shown consistent performance, with a 39.17% return over the past year, supported by strong financial results, including a significant increase in profits and a low Debt to EBITDA ratio of 1.00 times. Additionally, high institutional holdings at 37.8% indicate strong confidence from knowledgeable investors, further contributing to the stock's upward momentum.
In the broader market context, Glenmark's short-term performance stands in stark contrast to the Sensex, which has seen a slight decline of 0.20% over the same week. This divergence highlights Glenmark's strong market position and investor confidence, especially given its consistent returns over the last three years. Despite a recent drop in delivery volume, the stock remains liquid enough for trading, suggesting that investor interest is still robust. Overall, the combination of positive financial results, strong institutional backing, and recent price performance contributes to the stock's rising trend.